Good afternoon, and welcome to Huron Consulting Group's webcast to discuss financial results for the first quarter 2024. As a reminder, this conference call is being recorded. Before we begin, I would like to point all of you to the disclosure at the end of the company's news release for information about any forward-looking statements that may be made or discussed on this call. The news release is posted on Huron's website. Please review that information along with the filings with the SEC for a disclosure of factors that may impact subjects discussed in this afternoon's webcast. The company will be discussing one or more non-GAAP financial measures. Please look at the earnings release and on Huron's website for all of the disclosures required by the SEC, including reconciliation to the most comparable GAAP numbers. And now I would like to turn the call over to Mr. Mark Hussey, Chief Executive Officer and President of Huron Consulting Group. Mr. Hussey, please go ahead.

Good afternoon, and welcome to Huron Consulting Group's First Quarter 2024 Earnings Call. With me today are John Kelly, our Chief Financial Officer; and Ronnie Dail, our Chief Operating Officer. Our first quarter results reflect our ongoing focus on achieving consistent revenue growth and margin expansion. Revenues grew 12% over the first quarter of 2023, driven by strong growth in our Healthcare segment as well as continued growth in our Education segment, which furthers the segment's multiyear growth trajectory. Our strong growth in the first quarter of 2023 was achieved on top of strong growth in the year-ago quarter with Q1 2023 growth of 22% over the first quarter of 2022. Our first quarter results also demonstrate our commitment to delivering on the growth strategy and financial goals shared at our 2022 Investor Day, consisting of low double-digit annual revenue growth and expanding our adjusted EBITDA margins to mid-teen levels, leading to an annual high-teen percentage adjusted EPS growth. We believe achieving our financial goals together with a balanced capital deployment strategy that prioritizes moderate leverage, share repurchase, and targeted M&A will drive strong returns for our shareholders over time. I'll now share some additional insight into the progress we've made on our strategy while providing color into our first quarter performance. As a reminder, to achieve our goals, we're committed to executing against five strategic pillars. The first pillar of our strategy is to continue accelerating growth in our largest industries, healthcare and education, where we're focused on building upon our leading competitive positions. In the Healthcare segment, first quarter revenues grew 21% over the prior year quarter. The increase in revenues in Q1 of 2024 was driven by strong broad-based demand across our performance improvement, digital, strategy and innovation, and financial advisory offerings. The operating environments for many healthcare organizations are mixed in recent months. Some health systems continue to face strained financial positions, driving continued demand for our performance improvement and distressed-focused financial advisory offerings. Other healthcare providers have seen margins improve, and they're now seeking opportunities to evolve their strategies and advance their competitive positions by making strategic and operational investments. These organizations are creating demand for our digital, strategy and innovation, and non-distressed financial advisory offerings. As part of Huron's growth strategy, we continue to diversify our Healthcare service portfolio over time to meet the broader needs in the market, which has yielded greater consistency in this segment's financial performance. We've expanded the offerings within our performance improvement business while growing our Healthcare-focused strategy innovation, digital, and financial advisory offerings. If you look back to 2014, ten years ago, our performance improvement offerings represented virtually 100% of segment revenues. Fast forward to 2023, we diversified our portfolio so that performance improvement offerings represent only 46% of Healthcare segment revenues. We're confident that these investments we're making to expand our healthcare offerings are paying off, and we believe we're well positioned to address the wide array of opportunities and challenges facing our hospital and health system clients. Education segment revenues grew 7% in the first quarter of 2024 over the prior year quarter, driven by strong demand for our digital services and products. The education industry continues to face wide-ranging pressures, from top-line challenges including difficulty meeting enrollment and fundraising goals, more challenging research funding sources, to cost and regulatory pressures, including increased governmental scrutiny, workforce disruptions, and the need to make significant technology investments. The clients require a broad array of services and products to help them address these issues. We continue to strengthen and expand our offerings in the education industry to comprehensively address our clients' needs. We're the leading firm in the industry serving research institutions. The challenges of managing the highly complex research enterprises are increasing due to declines in funding for federal and commercial research and increased costs to conduct research. Research mission is critical to our client base, and our research businesses continue to be a strong source of growth for our Education segment and a differentiator for our services among the most prominent research institutions. We continue to invest in strengthening our offerings in this area, including our Huron Research Suite software, which is the predominant product in the market with over 600,000 users and over 500 institutions. The strength of our offering has yielded a client retention rate of over 99% across our suite of products. We also continue to expand our offerings to serve the broader needs of our mission-driven clients, particularly in education. For example, a recent acquisition of GG+A, one of the top philanthropy consulting firms, is creating new opportunities not only in education but also across healthcare and other non-profit clients. Another example of our expanded offerings is our athletics practice. We began to focus on university athletics in 2020. And to date, we have worked with over 50 institutions, ranging from the top Division 1 conferences to FCS and smaller institutions, many of which are facing increasingly complicated operating environments stemming from the dramatic changes taking place in intercollegiate athletics. We help these organizations to evaluate and execute upon the conference and athletic department strategies, which often have an outsized impact on the financials, enrollment, and branding of our large academic clients. Our Healthcare and Education businesses have market tailwinds, which continue to propel their growth. Our leading competitive positions, deep client relationships, high-quality delivery, and wide array of offerings position us well to be the partner of choice for our health system, university, and research-focused clients. Our second strategic pillar is focused on growing our commercial industry presence. In the first quarter of 2024, Commercial segment revenues were largely flat, driven by increases in revenue for our financial advisory offerings, partially offset by declines in our strategy and innovation as well as digital offerings. We continue to see our commercial clients taking a more cautious approach to executing large-scale initiatives and strategy-related engagements as uncertainties in the macroeconomic environment persist. Our distressed financial advisory business continues to have a solid outlook, although at a more moderate level than the strong record results achieved in 2023. With our focused strategy, we believe the commercial industries will create new avenues of growth for Huron. The mix of our digital, strategy, and financial advisory offerings has created a more balanced portfolio from which we can continue to grow our presence in financial services, industrials and manufacturing, and energy and utilities while providing more consistency in our financial performance in different market cycles. Now let me turn to our third strategic pillar, advancing our integrated Digital platform. In the first quarter of 2024, Digital capability revenues grew 10% over the first quarter of 2023, driven by growth across the Healthcare and Education segments. In 2023, our Digital capability grew to over $0.5 billion, a key milestone for that business and a testament to the collective investments we've made in technology, data, and analytics across all industries. We continue to be a market leader in our digital offerings. We were named best in class in healthcare for ERP business transformation and implementation leadership as well as IT consulting services in the payer market. We've also been awarded recognitions for driving innovation by other technology partners. And we're incredibly proud of the work we're doing and how we continue to expand our offerings to meet the rapidly evolving technology, data, and analytics needs of our clients. Intelligent automation, including the use of generative AI, is one area that is of great prominence and exploration in the market today. Our automation, analytics, and AI services revenues grew to over $50 million in 2023, demonstrating the value we bring to our clients and the growing significance of these advanced technologies in the market. Our work today spans advising clients on their intelligent automation strategies and road maps, including the data foundation needed to be successful through to the implementation of distinct use cases and comprehensive intelligent automation programs. And we provide two brief examples of how we're working with clients to apply AI. First, we're working with a commercial plan to establish a centralized AI capability center that will provide a platform to responsibly govern their AI program while also incubating high-impact solutions across their business. Second, we're working with a health system to leverage generative AI to expedite the clinical appeals process as part of their revenue cycle to reduce the administrative burden of inefficient reimbursement. These are only two examples of many that we're leaning in to enable our clients' businesses through the use of AI. Expanding our digital capabilities, including our intelligent automation offerings, through organic and inorganic investments will continue to be an important driver of growth across our business for many years to come as our clients focus on driving growth and productivity in their own highly competitive markets through the use of technology, data, and analytics. Now let me turn to our last two strategic pillars, which are more financially focused. First, we're executing on our margin improvement levers to achieve enhanced profitability. As it relates to margin expansion, a company-wide focus on improving profitability has yielded solid results. In 2020 to 2023, our full-year adjusted EBITDA margin has increased by 200 basis points, and full-year adjusted diluted earnings per share has increased by 128%. We continue to feel confident in our ability to improve our margins across our robust global platform, which will drive further efficiency as we scale while continuing our focus in areas such as driving improved utilization, pricing realization, and SG&A leverage. Our final pillar focuses on deploying capital to accelerate our strategy and return capital to our shareholders. Since our Investor Day in March of 2022 and through the quarter just ended, we repurchased 3.6 million shares at a weighted average price of $78.36, representing 16.5% of our common stock outstanding as of December 31, 2021. In 2024, we expect to execute our balanced capital allocation strategy across share repurchases, debt repayment, and tuck-in acquisitions. We believe that combining the capabilities and talent from acquisitions to enhance our competitive position, such as the recent GG+A acquisition, will drive strong growth and returns for our shareholders. And finally, let me acknowledge the heart of our strategy, our people. We have and will continue to invest in our incredibly talented team and strong collaborative culture. Our competitive advantage is driven by the strength and depth of our team. Our company culture drives how we work together to deliver on the most complex challenges of our clients and creates an environment where we're constantly innovating new offerings and advancing our business collectively as a unified team. Our ability to attract and retain top talent is demonstrated by our headcount growth of 41% from the end of 2021 to the end of 2023, coupled with consistently low attrition and high engagement scores. Our distinct culture, coupled with strong career advancement and development opportunities, provides a stable platform of ongoing growth not only for our people but also for our business. And now let me turn to our outlook for the year. Today, we affirm our 2024 revenue and adjusted EBITDA margin guidance, and we're raising our adjusted earnings per share guidance to a range of $5.60 to $6.10. We continue to believe our growth trajectory is strong given the expected demand in our end markets across healthcare, education, and commercial, our strong competitive positions and our deep client relationships. Given our focus, we have a unique breadth in our offerings, depth in our talent, and relevance in our subject matter expertise that allows us to be nimble and innovative while having the credentials and experience to compete and win against much larger competitors. Let me close by saying that our commitment to our growth strategy is evident in our recent performance, including our first quarter results. Our progress would not be possible without the focus and dedication of our entire team, and I want to thank all of them for supporting each other, our clients, and our business as we strive to make a lasting impact in the work that we do each and every day. Now let me turn it over to John for a more detailed discussion of our financial results. John?

Thank you, Mark, and good afternoon, everyone. Before I begin, please note that I will be discussing non-GAAP financial measures, such as EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and free cash flow. Our press release, 10-Q, and Investor Relations page on the Huron website have reconciliations of these non-GAAP measures to the most comparable GAAP measures, along with the discussion of why management uses these non-GAAP measures and why management believes they provide useful information to investors regarding our financial condition and operating results. Before discussing our financial results for the quarter, I'd like to acknowledge housekeeping items. First, our first quarter results reflect the acquisition of GG+A, which closed on March 1. As such, one month of GG+A's operating results are included within the Education segment. Second, in conjunction with the continued refinement of our operating model, we reclassified certain revenue-generating professionals within our Digital capability from our Healthcare and Education segments to our Commercial segment, reflecting the flexibility of these professionals to provide services across all of our industries, inclusive of healthcare and education. We have provided supplemental materials to provide additional details to this reclassification, which are posted on the Investor Relations section of our website. Now I will share some of the key financial results for the first quarter. Revenues for the first quarter of 2024 were $356 million, up 12% from $317.9 million in the same quarter of 2023. The increase in revenues for the quarter was driven by strong growth in our Healthcare segment and continued growth in our Education segment. Net income for the first quarter of 2024 was $18 million or $0.95 per diluted share compared to net income of $13.4 million or $0.68 per diluted share in the first quarter of 2023. Our effective income tax rate in the first quarter of 2024 was negative 2.5% as we recognized an income tax benefit on our income before taxes driven primarily by discrete tax benefits for share-based compensation awards that vested during the quarter and nontaxable gains on the investments used to fund our deferred compensation liability. Adjusted EBITDA was $33.8 million in Q1 2024 or 9.5% of revenues compared to $29.5 million or 9.3% of revenues in Q1 2023. The increase in adjusted EBITDA for the quarter was primarily due to the increase in segment operating income partially offset by an increase in corporate expenses, which included certain third-party legal expenses that are not expected to continue at the same level in future quarters. Adjusted net income was $23.3 million or $1.23 per diluted share in Q1 2024 compared to $17.1 million or $0.87 per diluted share in the first quarter of 2023, resulting in a 41% increase in adjusted diluted earnings per share over Q1 2023. Now I'll discuss the performance of each of our operating segments. The Healthcare segment generated 51% of total company revenues during the first quarter of 2024. This segment posted revenues of $180.7 million, up $31.7 million or 21.3% from the first quarter of 2023. The increase in revenues in the quarter reflects strong demand for our performance improvement, digital, strategy and innovation, and financial advisory offerings. Consulting and Managed Services and Digital capabilities grew 22% and 19%, respectively, in the first quarter, reflecting the continued broad-based demand for our offerings. Operating income margin for Healthcare was 23.6% in Q1 2024 compared to 21.6% in Q1 2023. The increase in margin is primarily due to revenue growth that outpaced compensation costs for our revenue-generating professionals, partially offset by an increase in practice administration and meeting expenses as a percentage of revenues. The Education segment generated 31% of total company revenues during the first quarter of 2024. The Education segment posted revenues of $111.6 million, up $7.4 million or 7.1% from the first quarter of 2023 and was achieved on top of strong growth in the year-ago quarter with Q1 2023 growth up 29% over Q1 2022. Revenues in the first quarter of 2024 included $1.3 million from our acquisition of GG+A. The increase in revenues in the quarter was driven by strong demand for our technology and analytics services software products within our Digital capability. The operating income margin for Education was 19.7% for Q1 2024 compared to 22.2% for the same quarter in 2023. The decrease in operating income margin in the quarter was primarily driven by increased compensation costs for our revenue-generating professionals as a percentage of revenue partially offset by a reduction in contractor expenses. The commercial segment generated 18% of total company revenues during the first quarter of 2024 and posted revenues of $63.6 million compared to $64.7 million in the first quarter of 2023. Revenues were largely flat in the quarter with increases in demand for our financial advisory offerings offset by declines in revenue within our strategy and innovation and digital offerings. Operating income margin for the Commercial segment was 22.1% for Q1 2024 compared to 21.7% for the same quarter in 2023. The increase in operating income margin in the quarter was primarily driven by decreases in compensation costs for our revenue-generating professionals. Corporate expenses not allocated at the segment level and excluding restructuring charges were $52.5 million in Q1 2024 compared to $44.1 million in Q1 2023. Unallocated corporate expenses in the first quarter of 2024 and 2023 included $2.4 million and $1.9 million, respectively, of expense related to the increase in the liability of our deferred compensation plan, which is offset by the investment gain on the assets used to fund that plan reflected in other income. Excluding the impact of the deferred compensation plan in all periods, unallocated corporate expenses increased $8 million, primarily due to increases in legal expenses, compensation expenses for our support personnel, and other losses. The legal expenses, which are not expected to continue at the same level in future quarters, primarily related to professional fees for a legal matter where Huron is the plaintiff and M&A-related expenses. Now turning to the balance sheet and cash flows. Total debt as of March 31, 2024, was $574 million, consisting of our $275 million term loan and $299 million of borrowings on our revolver. We finished the quarter with cash of $19 million for net debt of $555 million. This was a $243 million increase in net debt compared to Q4 2023, primarily due to the payment of our annual cash bonuses, share repurchases, and the acquisition of GG+A, all during the quarter. Regarding share repurchases, during the quarter, we used $62.3 million to repurchase approximately 625,000 shares, representing 3.4% of our common stock outstanding as of December 31, 2023. As of March 31, 2024, $24 million remained available for share repurchases under our current share repurchase program. We expect the pace of share repurchase activity to moderate through the remainder of the year. Our leverage ratio, as defined in our senior bank agreement, was 2.7x adjusted EBITDA as of March 31, 2024, compared to 2.8x adjusted EBITDA as of March 31, 2023. As a reminder, our first quarter typically represents a seasonal high leverage ratio given the payout of our annual bonuses in March. Cash flow used in operations in the first quarter of 2024 was $130.7 million. We used $8.8 million to invest in capital expenditures, including internally developed software costs and purchases of property and equipment, resulting in negative free cash flow of $139.5 million. We continue to expect full-year free cash flow to be in a range of positive $115 million to $145 million. DSO came in at 91 days for the first quarter of 2024 compared to 87 days for the fourth quarter of 2023 and 83 days for the first quarter of 2023. DSO was elevated during the first quarter of 2024 relative to the other periods. We do serve larger healthcare and education industry projects with contractual payment terms that will result in cash payments in the second and third quarters of 2024. We expect DSO to normalize in the 75- to 85-day range by the end of the year. Finally, let me turn to our guidance for the full year 2024. As Mark mentioned, we are affirming our revenue and adjusted EBITDA guidance with revenues before reimbursable expenses in a range of $1.46 billion to $1.54 billion and adjusted EBITDA in a range of 12.8% to 13.3% of revenues. Today, we are raising our adjusted non-GAAP EPS to a range of $5.60 to $6.10, reflective of a now lower anticipated full-year effective tax rate in the range of 26% to 28% and a lower weighted average diluted share base for the year based on the accelerated pace of share repurchases during the first quarter. Thanks, everyone. I would now like to open the call for questions. Operator?

One moment for our first question, which comes from Andrew Nicholas of William Blair & Company.

I wanted to start on the Healthcare segment's growth. Really strong quarter on that front. Mark, you alluded to kind of broad-based demand across that segment. But I was hoping you could unpack where the growth rates fit across PI, digital, strategy and innovation, financial adviser. Just kind of getting a sense for under the hood kind of where the strength is, if there is a rotation between the different segments as the end market seems to get a bit healthier with time. That would be really helpful to kind of understand.

Yes. John, why don't you give some color into some of the trends by area?

Yes, I'm happy to do that. I'll start there, and then Mark, you can give the color commentary. From a breakout within the Healthcare business, we continue to see a lot of strength, Andrew, within our consulting part of the business, and particularly our performance improvement part of the business. Year-over-year, that was up north of 20% between the two years. So consistent with Mark's comments, that's a part of the business where even though year-over-year we've seen some improvement in the industry in terms of average profit margins and things like that, there's still a number of clients that are facing financial strain right now, and we see continued demand for those types of projects. From a Digital perspective, we continue to see really good growth overall, high-teen growth from a Digital perspective. I think that's reflective of really the other part of the market where we see clients that have reached more financial stability now turning around and really starting to execute on some of their investment plans, which oftentimes includes improving the digital infrastructure. So we've seen good growth there. And then you referenced as well strategy and financial advisory. Those are two smaller bases of revenue within the business, but areas that are really performing well. And so from a percentage perspective, they're up over 25% year-over-year. But they're starting from a smaller base. But I think those are both areas where we see a lot of demand with our clients right now in terms of working on the strategies as well as starting to think about balance sheet considerations where our financial advisory team plays really well with those clients. So hopefully, that gives some color.

Yes. And I would say, Andrew, my comment on the mixed view of margins within the sector. It really depends a little bit on market-specific situations. But I would tell you that collectively, in those systems that are having performance improvement issues, there are also aspects that address every one of the businesses. So it's not as if performance improvement is only on one side and not on the other. So it really is just maybe leaning more heavily on one side of that mix. And I'd say our power in the market right now is really our ability to bring that team together very collectively in coordination and seamlessly across each client situation, which has really enabled us to differentiate and have a very strong offering for the clients in terms of driving value.

I'll add one final point regarding our strategy and our robust financial advisory business. While the exact percentages may not be the best indicators, a year ago, these were low single-digit million-dollar sectors for us, and now they are operating at the mid-teens million-dollar level. We're continuing to invest in this growth and observe a strong demand trajectory. This is an area of our portfolio that we are quite enthusiastic about as it contributes to our overall business growth.

That's really helpful. I guess I would have thought maybe a little bit more of a rotation, but it sounds like everything is still very much hitting on all cylinders. Appreciate that. And then maybe for my follow-up on the margin front, I'm pretty encouraged by the margin expansion even with a little bit lower utilization in the quarter and some really strong headcount growth. So can you talk about kind of the ability to expand margins despite lower utilization? And then somewhat relatedly, I think it's up about 20 basis points year-over-year in the first quarter. You stuck to the full-year margin expansion guidance. So what dynamics allow you to expect maybe more margin expansion on a year-over-year basis through the rest of the year and in the second half as opposed to the start of the year?

Sure, Andrew, I can start there. We encountered several unexpected items during the quarter that contributed to additional expenses. Nonetheless, we are pleased with the 20 basis points of margin improvement for the quarter despite these costs. One item was a practice meeting held by one of our larger teams. We typically hold one of these meetings annually, and while it’s not always the same team, the corresponding large event took place in the fourth quarter this year and during the first quarter last year, creating an unfavorable comparison. This alone impacted margins by about 70 basis points. Additionally, as I mentioned earlier, we had some expenses related to deals that arose during the quarter, including one-time items concerning earn-out valuations connected to the GG+A acquisition. We also experienced a rise in legal costs during the quarter that we do not expect to recur at that level as the year progresses. These factors presented headwinds during the quarter, involving items that have been adjusted out, like earn-out fair value adjustments, along with other one-time occurrences that are unlikely to repeat. Despite the 20 basis points of improvement in the first quarter, we are confident in our ability to accelerate margin expansion as the year continues.

Our next question comes from the line of Tobey Sommer of Truist Securities.

This is Jasper Bibb on for Tobey. Can you maybe frame for us what's assumed for Healthcare performance improvement growth in your '24 guidance? And maybe I missed it in the earlier discussion about different practice groups within Healthcare, but how is Studer Group doing right now?

Yes. So from a performance improvement perspective during the year, I think that's an area of the business where the guidance initially at the beginning of the year called for more mid- to upper single-digit growth within that business just because they had such a record performance in 2023. Obviously, we're off to a good start in that business with the growth that I described in the first quarter that's outpacing that. So that's an area where there's potential for upside as the year goes on. But these assumptions were relatively conservative in the original plan. And then as far as the people business goes, the Studer Group business that you referred to, that's an area of the business where we're planning for modest, call it, low single-digit growth during the year.

Got it. That's helpful. I guess maybe stepping back, any thoughts on the FTC's move to ban non-competes and what that might mean for your business?

Yes. This is Mark. At this point, first of all, we all know it's going to get litigated. So I don't think we really know the outcome for several months. But having said that, we are not overly concerned about it in our business. It's certainly something we use and manage all the time, and candidly, might be more of an opportunity as an example for us. But it's not something that right now is paramount in terms of our concern list.

Got it. Last one for me, like headcount growth came in a lot faster than we expected this quarter, and maybe some of that was GG+A, but how should we think about the pace of headcount adds and the corresponding impact on utilization over the balance of the year?

Yes. There are a few factors to consider regarding headcount. You mentioned the addition of GG+A, which accounts for about 100 full-time employees. We are also expanding our managed services capabilities from a global delivery standpoint, particularly with our team in India. This has led to an increase in headcount as we secure new projects in that area, although this tends to be less expensive compared to other sectors. Additionally, we experienced record low attrition in the first quarter of this year, following a trend of low attrition throughout 2023. All these elements contribute to a generally low attrition environment, along with targeted increases in specific areas where we are focusing on growth.

Our next question comes from the line of Bill Sutherland of Benchmark.

Mark and John, I just want to make sure I got the speaker on. Can you hear me?

Yes. Sounds good.

Good. Cool. So just to follow up, I guess, on that headcount question. It was particularly strong in Healthcare quarter-on-quarter. I think it was like 11%. So I guess all those factors, John, you just referred to apply to Healthcare. Is there any other color, particularly for the segment? And then how do we think about kind of sequentially for the rest of the year, the headcount trend there?

A significant portion of the headcount growth you see is due to the expansion of our managed services team over the past year. This area continues to show strong growth potential. We are actively hiring and bringing in talent to meet our clients' needs and support ongoing growth for the rest of the year. Looking at it from a longer-term perspective, it is reasonable to expect that headcount growth will align with revenue growth for the year. However, as the year progresses, there may be some areas where we increase investments, potentially leading to higher utilization with slightly less headcount growth. Overall, we believe headcount percentage growth and revenue percentage growth will generally trend the same for the remainder of the year.

Okay. I know utilization can bounce around quarter-to-quarter. Pretty big moves in Digital and Consulting, Digital up, Consulting down. Consulting I assume is basically just catching up with the hiring, including the acquisition. I'm not sure what their utilizations were. But is that fair to say? And then on Digital, is that sustainable?

I'll offer two things, Bill, on the Consulting side. There was a little bit of pressure on the utilization metric related to the acquisition just in the first month by onboarding some of those employees. Again, the low attrition environment in general is another factor that we have a very low attrition environment that can put a little bit of pressure on the utilization metric. From a Digital perspective, I think that we actually have room to improve that metric as the year goes from where it landed in the first quarter. So it was up year-over-year. It was actually down a little bit sequentially, if you look at the fourth quarter versus the first quarter. So we think that there's more room to run on that metric. And the final point I made when we're talking about expenses earlier, I referenced the large team meeting that we had that was about 70 basis points of expense during the quarter. That also has a utilization impact. And we don't want to induce a precision around it. We estimate that the impact for the Consulting utilization related to that was about 1.5%. So I think that that's not clearly a significant kind of onetime item that you'd see in the first quarter.

Got it. Did you discuss capital allocation in the prepared remarks? I had to step away for a moment. What are your thoughts on capital allocation now that you've completed a significant share buyback? I know you're going to moderate, but how do you view the M&A environment? Are there good opportunities, or are you planning to watch and see for now?

Bill, it's Mark. We are optimistic about our merger and acquisition pipeline. We have consistently been selective regarding the opportunities we pursue. We are getting to know various companies and sometimes collaborating in the market, which often serves as a precursor to considering an acquisition. Over the past year, we have evaluated numerous companies and continue to find promising opportunities that we feel confident about. I believe these opportunities generally fall into the tuck-in category, though some may be somewhat larger than GG+A and others could be a bit smaller. While we cannot predict precisely when these acquisitions will occur, I do anticipate that we will be more active for the remainder of the year.

Our next question coming from the line of Kevin Steinke of Barrington Research Associates.

So you talked about some continuing caution from clients in the Commercial segment about moving forward with digital and strategy and innovation projects. I believe on your last call, the fourth quarter call, you talked about some seeing some signs that those areas could pick up in 2024. Is that still the case? Or do you think clients have become a little more cautious over the last three months or so here?

We still see signs that suggest there could be an increase as 2024 progresses. The size of the pipeline and the opportunities within it are encouraging, and there are some excellent projects included. The main point is that there is significant demand from our clients for the services we offer. However, some caution stems from the current macroeconomic uncertainty, which has made clients more hesitant to initiate projects and more deliberate in their planning. We are navigating through this period of uncertainty, but we firmly believe that there is a strong market need, and it's really a question of timing rather than possibility for a rebound.

I think it's well said. I think it's the inflationary environment, the economy. But when you look at the election year, obviously, is on the minds of several of our clients as well. But I think that John said it right. The pipeline is actually pretty good. It's more a matter of how does the timing play out with respect to specific opportunities. But we're definitely getting our share of that and feeling good about our offerings and being competitive in the market.

Okay. And then also on Commercial, you mentioned continued growth in financial advisory. Is that an area as hot as it has been? I know you're going to be coming up against some more difficult comparisons here, but is that slowing at all or as strong as it's been or strengthening? Just kind of wondering directionally how that's trending.

I think the context I'd provide is that last year, that business experienced a high demand and achieved record revenue. We expect the growth rate to slow down compared to last year, but the demand remains strong. There are still many inquiries for our services in that sector, and our team is achieving considerable success with those opportunities. When that business is doing well, it contributes a high margin to our portfolio. We remain optimistic about the future of that business as the year progresses, even if the growth isn't as rapid as it was during the record-setting year of 2023.

Okay. And then just lastly, I know you reiterated the full-year 2024 revenue guidance, but any change at the segment level in terms of the growth outlook in each segment that gets you to that consolidated number?

I think it's probably a little too early to adjust the guidance here, Kevin. Obviously, the Healthcare business is off to a great start. We continue to feel really good about the pipeline there. So I think that might be an area where you could expect to see potentially a little bit of upside. And the first quarter for the Commercial segment was a little bit slower. That was more flat during the quarter. So that might be where you'd see a little bit of pressure on the growth rate. But we'll continue to execute throughout the year, and I would anticipate by the time we get to the next call, we can refine that a little bit. But those will be maybe in broad strokes where we see a little bit of increased demand versus where it's been a little bit softer.

Okay. Lastly, John, I don't know if you called out the dollar amount of the legal expenses that you don't expect to recur after the first quarter.

So there's always some level of legal expense in our SG&A. But I described, Kevin, the amount that was above and beyond will be the normal run rate, will be a couple of million dollars.

Our next question comes from Moshe Katri of Wedbush Securities.

Congratulations on your outstanding results. I believe Huron is the only company in this sector that is actively recruiting. What does your guidance for calendar year 2024 indicate regarding organic headcount growth? That’s my first question.

In terms of the guidance, so our revenue growth rate for the year from a projection perspective, the midpoint guidance was around 10%. And the range around that was 7% to 13%. So in terms of us expanding our talent pool during the year, we're expecting that to basically be of a similar trajectory as the revenue growth. So around that 10% range.

Understood. Regarding visibility, could you provide an update on the Healthcare, Education, and Commercial sectors compared to three months ago? Has it changed, improved, or worsened? How would you describe it?

Within the Healthcare segment, we've seen improvements during the quarter in several areas. We've identified promising opportunities in our pipeline and have successfully converted many of them into backlog. This has enhanced our visibility. Additionally, we have projects with performance-based fees, and our teams are executing well on these, giving us confidence in potential revenue growth as the year progresses. Healthcare has shown improvement, while Education remains consistent with our position from three months ago, which is encouraging as we continue to experience strong and widespread demand across our offerings. However, the Commercial sector shows a robust pipeline but has exhibited slower short-term conversion, particularly for some digital projects. There seems to be more caution in that area compared to three months ago.

Yes. One addition on that is when you look at our financial advisory offerings, which we talked a little bit about, tend to have a very, very short sales cycle. I mean literally could be within a week to when an engagement might start. So those are the kind of things in that environment where it's kind of a balance to some of the other areas that we've seen a little bit of delay in decision-making or projects that are just pushed off.

Yes, understood. So essentially, the pipeline in Digital is strong, but it isn't converting, or it's not converting on time?

In Commercial, yes. I would say in the other parts of the business, it's either stronger or Healthcare has been stronger. Education has been fairly consistent. In Commercial for Digital, there is a good-looking pipeline, but the conversion has been slower than historical norms.

Can we get some transparency regarding the headcount of your India operation? Where was it a year ago, and what do you expect it to be in the next year or two?

So from a total headcount perspective, it's roughly 28% of our total workforce is in India. And the three areas that are most prominently delivered by our global team in India is our Digital business, which has about 1,000 of those employees; our Managed Services business, which has about 500 or 600 of those employees; and then we do support our corporate enterprise with our team members in that location as well, which makes up the remainder of the headcount. And from a growth perspective, that's been an area that's been growing very strongly. If you were to go a little further back than just last year, it's grown significantly. Five years ago, it was probably low hundreds in terms of employees that we had there up to the 2,000 rough number that we have now in India. I'd say year-over-year, it was still a strong growth area, but I think just matured a little bit, I'd say, over the course of the past year.

Thank you. Seeing no more questions in the queue, I'd like to turn the call back to Mr. Hussey.

Thanks for spending time with us this afternoon. We look forward to speaking with you again in July when we announce our second-quarter results. Have a good evening.

That concludes today's conference call. Thank you, everyone, for your participation.